Sysmex Corporation (JP:6869)
:6869
Want to see JP:6869 full AI Analyst Report?
6869 Stock Chart & Stats
¥1437.00
¥11.50(0.40%)
At close: 4:00 PM EST
¥1437.00
¥11.50(0.40%)
Day’s Range― - ―
52-Week Range¥1,246.00 - ¥2,563.50
Previous CloseN/A
Volume1.43M
Average Volume (3M)2.38M
Market Cap
¥931.36B
Enterprise Value¥845.95B
Total Cash (Recent Filing)¥84.12B
Total Debt (Recent Filing)¥70.48B
Price to Earnings (P/E)26.1
Beta0.28
Next Earnings
Aug 11, 2026EPS Estimate
10.12Next Dividend Ex-DateN/A
Dividend Yield1.88%
Share Statistics
EPS (TTM)56.89
Shares Outstanding629,480,100
10 Day Avg. Volume2,693,210
30 Day Avg. Volume2,377,620
Financial Highlights & Ratios
PEG Ratio-0.71
Price to Book (P/B)1.69
Price to Sales (P/S)1.71
P/FCF Ratio20.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside4.38% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)67.1
Revenue Forecast (FY)¥534.06B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables And ServicesSysmex's model pairs capital instrument sales with high-margin, recurring consumables and multi-year service contracts. This installed-base driven revenue creates predictable, usage-linked cash flow and strong customer lock-in, supporting durable top-line and margin resilience over time.
Conservative Balance SheetA large and growing equity base with historically low leverage gives Sysmex financial flexibility to invest in R&D, product rollouts, and M&A, and to withstand industry cyclicality. This conservatism reduces solvency risk and supports long-term capital allocation choices.
Strong Margins With Positive Operating Cash FlowConsistently healthy gross and net margins combined with substantial operating cash generation underpin durable internal funding for R&D, capex, and dividends. Even with volatility, positive OCF and recurring margins support sustained profitability and reinvestment capacity.
Bears Say
2026 Revenue And Profit DeteriorationA meaningful step-down in revenue and operating profit signals weakening demand or execution issues that can persist beyond a quarter. Prolonged top-line softness compresses reinvestment ability, slows installed-base growth, and can lead to margin pressure and lower long-term growth potential.
Rising Total DebtThe recent increase in absolute debt reduces financial headroom relative to prior years. If earnings remain under pressure, higher leverage raises interest and refinancing risks, constrains strategic options, and limits the firm's ability to fund new product rollouts or support customers during downturns.
Volatile Free Cash Flow ConversionInconsistent FCF conversion driven by working capital and investment swings makes cash availability unpredictable. This volatility hampers reliable funding for R&D, dividends, or buybacks, and raises execution risk for multi-year projects dependent on steady internal cash generation.
Sysmex News
6869 FAQ
What was Sysmex Corporation’s price range in the past 12 months?
Sysmex Corporation lowest stock price was ¥1246.00 and its highest was ¥2563.50 in the past 12 months.
What is Sysmex Corporation’s market cap?
Sysmex Corporation’s market cap is ¥931.36B.
When is Sysmex Corporation’s upcoming earnings report date?
Sysmex Corporation’s upcoming earnings report date is Aug 11, 2026 which is in 65 days.
How were Sysmex Corporation’s earnings last quarter?
Sysmex Corporation released its earnings results on May 14, 2026. The company reported ¥2.84 earnings per share for the quarter, missing the consensus estimate of ¥5.931 by -¥3.091.
Is Sysmex Corporation overvalued?
According to Wall Street analysts Sysmex Corporation’s price is currently Undervalued.
Does Sysmex Corporation pay dividends?
Sysmex Corporation pays a Notavailable dividend of ¥19 which represents an annual dividend yield of 1.88%. See more information on Sysmex Corporation dividends here
What is Sysmex Corporation’s EPS estimate?
Sysmex Corporation’s EPS estimate is 10.12.
How many shares outstanding does Sysmex Corporation have?
Sysmex Corporation has 629,480,100 shares outstanding.
What happened to Sysmex Corporation’s price movement after its last earnings report?
Sysmex Corporation reported an EPS of ¥2.84 in its last earnings report, missing expectations of ¥5.931. Following the earnings report the stock price went up 0.075%.
Which hedge fund is a major shareholder of Sysmex Corporation?
Currently, no hedge funds are holding shares in JP:6869
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
6869 Stock 12 Month Forecast
Average Price Target
¥1,500.00
▲(4.38% Upside)
Technical Analysis
Options Prices
Currently, No data available
---